Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Talphera, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TLPH
Nasdaq
2834
talphera.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Talphera, Inc.
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Sep 3rd, 2026 6:30 am
Talphera (TLPH) Q2 2026 Earnings Call Transcript
- Aug 19th, 2026 3:28 pm
Talphera, Inc. Q2 2026 Earnings Call Summary
- Aug 13th, 2026 7:30 pm
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO Study Enrollment Hits 75% as ...
- Aug 12th, 2026 11:03 pm
Talphera Q2 Earnings Call Highlights
- Aug 12th, 2026 9:04 pm
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Aug 12th, 2026 2:05 pm
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
- Aug 5th, 2026 2:05 pm
Talphera, Inc. Q1 2026 Earnings Call Summary
- May 14th, 2026 6:30 am
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...
- May 13th, 2026 11:02 pm
Talphera Q1 2026 Earnings Call Transcript
- May 13th, 2026 3:40 pm
Talphera (TLPH) Q1 2026 Earnings Transcript
- May 13th, 2026 3:37 pm
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
- May 13th, 2026 2:05 pm
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
- May 7th, 2026 2:05 pm
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
- Mar 25th, 2026 6:30 am
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
- Mar 23rd, 2026 6:30 am
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
- Mar 18th, 2026 2:05 pm
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
- Mar 2nd, 2026 6:30 am
This Talphera Insider Increased Their Holding By 138% Last Year
- Dec 7th, 2025 5:50 am
Scroll